Literature DB >> 34213761

Mean corpuscular hemoglobin concentration: an anemia parameter predicting cardiovascular disease in incident dialysis patients.

Satoshi Yamaguchi1,2, Takayuki Hamano3,4, Tatsufumi Oka1, Yohei Doi1, Sachio Kajimoto1, Karin Shimada1, Ayumi Matsumoto1, Yusuke Sakaguchi5, Isao Matsui1, Akira Suzuki2, Yoshitaka Isaka1.   

Abstract

BACKGROUND: Hemoglobin levels usually decline before dialysis initiation. The influence of overhydration on anemia progression and iron sequestration is poorly documented. Furthermore, clinical implications of anemia at dialysis initiation remain to be elucidated.
METHODS: This multicenter retrospective cohort study enrolled incident dialysis patients. The patients were stratified by tertiles of overhydration rate (OH-R) defined by (BW - DW)/DW*100 (BW: body weight just before dialysis initiation, DW: dry weight). Time courses (6 months before, to 1 month after, dialysis initiation) of hemoglobin, C-reactive protein (CRP), and iron sequestration index (ISI) were examined using mixed effects models. We used Cox models to identify anemia parameters predicting subsequent cardiovascular disease (CVD).
RESULTS: Among the 905 enrolled patients, hemoglobin levels gradually decreased before dialysis initiation and rapidly increased thereafter. An inverse V-shaped time course was observed for CRP and ISI with an increase during dialysis initiation. Patients with a higher OH-R showed lower hemoglobin levels along with higher CRP and ISI levels before dialysis initiation. Mean corpuscular hemoglobin concentration (MCHC) was more stable before dialysis initiation than were mean corpuscular volume (MCV) and mean corpuscular hemoglobin (MCH). Low MCHC (< 32 g/dL) was independently associated with the incidence of nonatherosclerotic CVD. Patients with low MCHC tended to have increased left ventricular wall thickness and left atrial diameter.
CONCLUSIONS: Progression of anemia before dialysis among overhydrated patients may mainly occur through hemodilution and iron sequestration partly induced by inflammation. Low MCHC reflects left atrial overload and left ventricular hypertrophy and hence may predict nonatherosclerotic CVD.
© 2021. Italian Society of Nephrology.

Entities:  

Keywords:  Cardiovascular disease; Hemodilution; Hemoglobin dip; Iron sequestration

Mesh:

Year:  2021        PMID: 34213761     DOI: 10.1007/s40620-021-01107-w

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  2 in total

1.  Iron-regulatory proteins secure iron availability in cardiomyocytes to prevent heart failure.

Authors:  Saba Haddad; Yong Wang; Bruno Galy; Mortimer Korf-Klingebiel; Valentin Hirsch; Abdul M Baru; Fatemeh Rostami; Marc R Reboll; Jörg Heineke; Ulrich Flögel; Stephanie Groos; André Renner; Karl Toischer; Fabian Zimmermann; Stefan Engeli; Jens Jordan; Johann Bauersachs; Matthias W Hentze; Kai C Wollert; Tibor Kempf
Journal:  Eur Heart J       Date:  2017-02-01       Impact factor: 29.983

2.  Association of fluid retention with anemia and clinical outcomes among patients with chronic kidney disease.

Authors:  Szu-Chun Hung; Ko-Lin Kuo; Ching-Hsiu Peng; Che-Hsiung Wu; Yi-Chun Wang; Der-Cherng Tarng
Journal:  J Am Heart Assoc       Date:  2015-01-05       Impact factor: 5.501

  2 in total
  3 in total

1.  The Association Between Mean Corpuscular Hemoglobin Concentration and Prognosis in Patients with Acute Pulmonary Embolism: A Retrospective Cohort Study.

Authors:  Zhishen Ruan; Dan Li; Yuanlong Hu; Zhanjun Qiu; Xianhai Chen
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

Review 2.  Ferroptosis and its Role in Gastric Cancer.

Authors:  Renjun Gu; Yawen Xia; Pengfei Li; Defang Zou; Keqin Lu; Lang Ren; Hongru Zhang; Zhiguang Sun
Journal:  Front Cell Dev Biol       Date:  2022-06-30

3.  A Simple Nomogram for Predicting Osteoarthritis Severity in Patients with Knee Osteoarthritis.

Authors:  Qingzhu Zhang; Yinhui Yao; Jinzhu Wang; Yufeng Chen; Dong Ren; Pengcheng Wang
Journal:  Comput Math Methods Med       Date:  2022-09-02       Impact factor: 2.809

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.